DK3083947T3 - Prrs-virusvariant, cdna-klon af europæisk prrs-virus, samt anvendelser deraf - Google Patents

Prrs-virusvariant, cdna-klon af europæisk prrs-virus, samt anvendelser deraf Download PDF

Info

Publication number
DK3083947T3
DK3083947T3 DK14827219.8T DK14827219T DK3083947T3 DK 3083947 T3 DK3083947 T3 DK 3083947T3 DK 14827219 T DK14827219 T DK 14827219T DK 3083947 T3 DK3083947 T3 DK 3083947T3
Authority
DK
Denmark
Prior art keywords
prrs virus
cdna clone
european
variation
european prrs
Prior art date
Application number
DK14827219.8T
Other languages
Danish (da)
English (en)
Inventor
Andreas Gallei
Christoph Keller
Erik Schacht
Marieke Herrel
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Application granted granted Critical
Publication of DK3083947T3 publication Critical patent/DK3083947T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10041Use of virus, viral particle or viral elements as a vector
    • C12N2770/10043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK14827219.8T 2013-12-20 2014-12-19 Prrs-virusvariant, cdna-klon af europæisk prrs-virus, samt anvendelser deraf DK3083947T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13199177 2013-12-20
EP14175691 2014-07-03
PCT/EP2014/078929 WO2015092058A1 (en) 2013-12-20 2014-12-19 Prrs virus variant, european prrs virus cdna clone, and uses thereof

Publications (1)

Publication Number Publication Date
DK3083947T3 true DK3083947T3 (da) 2019-07-08

Family

ID=52347295

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14827219.8T DK3083947T3 (da) 2013-12-20 2014-12-19 Prrs-virusvariant, cdna-klon af europæisk prrs-virus, samt anvendelser deraf
DK19165389.8T DK3591042T5 (da) 2013-12-20 2014-12-19 PRRS-virusvariant, cDNA-klon af europæisk PRRS-virus samt anvendelser deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19165389.8T DK3591042T5 (da) 2013-12-20 2014-12-19 PRRS-virusvariant, cDNA-klon af europæisk PRRS-virus samt anvendelser deraf

Country Status (13)

Country Link
US (2) US10010601B2 (cg-RX-API-DMAC7.html)
EP (2) EP3591042B1 (cg-RX-API-DMAC7.html)
JP (3) JP6886291B2 (cg-RX-API-DMAC7.html)
KR (2) KR102446025B1 (cg-RX-API-DMAC7.html)
CN (1) CN105829528B (cg-RX-API-DMAC7.html)
AU (2) AU2014369774B2 (cg-RX-API-DMAC7.html)
CA (1) CA2930042C (cg-RX-API-DMAC7.html)
DK (2) DK3083947T3 (cg-RX-API-DMAC7.html)
EA (1) EA039060B1 (cg-RX-API-DMAC7.html)
ES (2) ES2940691T3 (cg-RX-API-DMAC7.html)
HU (1) HUE061768T2 (cg-RX-API-DMAC7.html)
MX (2) MX375528B (cg-RX-API-DMAC7.html)
WO (1) WO2015092058A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2826341C (en) 2011-02-17 2022-02-22 Boehringer Ingelheim Vetmedica Gmbh Live attenuated strain of european prrsv and vaccines thereof
BR112013020966B1 (pt) 2011-02-17 2020-05-26 Boehringer Ingelheim Vetmedica Gmbh Processo em escala comercial para produção do prrsv
DK3083947T3 (da) 2013-12-20 2019-07-08 Boehringer Ingelheim Vetmedica Gmbh Prrs-virusvariant, cdna-klon af europæisk prrs-virus, samt anvendelser deraf
US11332739B2 (en) 2016-08-05 2022-05-17 Hipra Scientific, S.L.U. Porcine reproductive and respiratory syndrome virus cDNA clone and uses thereof
KR102335864B1 (ko) * 2018-12-27 2021-12-06 주식회사 바이오포아 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신
WO2020138761A1 (ko) * 2018-12-27 2020-07-02 주식회사 바이오포아 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신
AU2019463018B2 (en) 2019-08-29 2025-11-06 Elanco Uk Ah Limited Porcine reproductive and respiratory syndrome vaccine virus
CN110894243B (zh) * 2019-12-16 2021-07-13 中国农业大学 一种猪蓝耳病毒嵌合抗原以及检测猪蓝耳病毒抗体的胶体金免疫层析试纸条
CN116134131A (zh) 2019-12-31 2023-05-16 伊利克斯根治疗公司 核酸和蛋白质向细胞和组织的基于温度的瞬时递送
JP2021153692A (ja) * 2020-03-25 2021-10-07 株式会社三共 遊技機
KR102319508B1 (ko) * 2020-07-27 2021-10-28 연세대학교 산학협력단 인체 감염형 낙타 유래 메르스코로나바이러스 검출용 바이오마커 및 이의 용도
CN113969267B (zh) * 2021-11-15 2024-02-27 中国农业大学 一种猪繁殖与呼吸综合征突变病毒及其构建方法与应用
WO2024077281A2 (en) * 2022-10-06 2024-04-11 Cornell University Genotyping and sequencing assays for prrsv
KR20240146158A (ko) * 2023-03-27 2024-10-08 주식회사 케어사이드 돼지생식기호흡기증후군 키메릭 바이러스 및 이를 이용한 백신 조성물

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137631A (en) 1959-12-01 1964-06-16 Faberge Inc Encapsulation in natural products
US3959457A (en) 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
US4015100A (en) 1974-01-07 1977-03-29 Avco Everett Research Laboratory, Inc. Surface modification
EP0000062A1 (en) 1977-06-07 1978-12-20 Joseph George Spitzer Vapor tap valve for aerosol containers used with inflammable propellants, and container provided therewith
US4205060A (en) 1978-12-20 1980-05-27 Pennwalt Corporation Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
ZA864879B (en) 1985-07-08 1987-03-25 Wallone Region Vaccines and diagnostics derived from boving diarrhoea virus
NZ222465A (en) 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
CA2290906C (en) 1991-06-06 2003-04-01 Stichting Centraal Diergeneeskundig Instituut Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
JPH07501049A (ja) 1991-10-14 1995-02-02 アクゾ・ノベル・エヌ・ベー ブタ生殖・呼吸系症候群ワクチン及び診断方法
FR2686097B1 (fr) 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ES2074950B1 (es) 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
DE69522984T2 (de) 1994-04-11 2002-04-25 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins
DK53595A (da) 1994-05-13 1995-11-14 Iberica Cyanamid Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
DK0732340T3 (da) 1995-03-14 2004-10-25 Akzo Nobel Nv Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle
ES2102971B1 (es) 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
US5866401A (en) 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
DK0835930T3 (da) 1996-10-09 2001-06-18 Akzo Nobel Nv Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV)
US20040224327A1 (en) 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2289980C (en) 1997-05-06 2010-07-20 Antonie Paul Van Nieuwstadt Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
NZ501264A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
JP3961222B2 (ja) 1999-03-08 2007-08-22 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー Prrsvワクチン
ES2348159T3 (es) 1999-04-22 2010-11-30 United States Department Of Agriculture Vacuna contra el sindrome respiratorio y reproductivo porcino basada en el aislado ja-142.
WO2002095040A1 (en) 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
WO2001059077A1 (en) 2000-02-08 2001-08-16 Regents Of The University Of Minnesota Porcine reproductive and respiratory syndrome virus and methods of use
EP1156111A1 (en) 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
EP1350840B1 (en) 2002-04-05 2012-05-09 Boehringer Ingelheim Vetmedica GmbH Adaptation sites of PRRSV
US7722878B2 (en) 2004-06-17 2010-05-25 Boehringer Ingelheim Vetmedica, Inc. PRRSV subunit vaccines
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
DE602006013270D1 (en) 2005-01-13 2010-05-12 Boehringer Ingelheim Vetmed Prrs-impfstoffe
WO2008121958A1 (en) 2007-04-02 2008-10-09 Boehringer Ingelheim Vetmedica, Inc. Use of prrsv vaccines to reduce pcv2 viremia
ES2389748T3 (es) * 2007-06-25 2012-10-31 South Dakota State University Virus del síndrome reproductivo y respiratorio porcino de tipo 1 norteamericano recombinante y métodos de uso
US20110117129A1 (en) 2008-08-25 2011-05-19 Boehringer Ingelheim Vetmedica, Inc. Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS)
WO2010084648A1 (ja) 2009-01-20 2010-07-29 シャープ株式会社 照明装置、表示装置、及びテレビ受信装置
ES2742262T3 (es) 2010-04-16 2020-02-13 Univ Gent Vacuna con protección cruzada para el virus del síndrome respiratorio y reproductivo porcino
BR112013020966B1 (pt) 2011-02-17 2020-05-26 Boehringer Ingelheim Vetmedica Gmbh Processo em escala comercial para produção do prrsv
CA2826341C (en) 2011-02-17 2022-02-22 Boehringer Ingelheim Vetmedica Gmbh Live attenuated strain of european prrsv and vaccines thereof
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
JP6260972B2 (ja) * 2012-02-14 2018-01-17 メリアル インコーポレイテッド 狂犬病タンパク質及びox40タンパク質の両方を発現する組換えポックスウイルスベクター並びに前記ベクターから製造されるワクチン
MX2014013964A (es) * 2012-05-17 2015-03-04 Zoetis Llc Vacunacion eficaz contral el virus del sindrome reproductivo y respiratorio porcino (prrs) antes del destete.
EP2968513A2 (en) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
CN105829906B (zh) * 2013-12-19 2020-11-03 皇家飞利浦有限公司 具有水/脂肪分离的相位敏感的反转恢复mri
DK3083947T3 (da) 2013-12-20 2019-07-08 Boehringer Ingelheim Vetmedica Gmbh Prrs-virusvariant, cdna-klon af europæisk prrs-virus, samt anvendelser deraf

Also Published As

Publication number Publication date
CA2930042C (en) 2022-06-21
ES2729838T3 (es) 2019-11-06
CN105829528B (zh) 2019-10-22
KR102270344B1 (ko) 2021-07-01
JP2021104028A (ja) 2021-07-26
DK3591042T3 (da) 2023-04-17
MX375528B (es) 2025-03-06
AU2014369774B2 (en) 2020-11-26
KR102446025B1 (ko) 2022-09-22
EP3591042A1 (en) 2020-01-08
MX2016007737A (es) 2016-09-07
KR20160099099A (ko) 2016-08-19
CA2930042A1 (en) 2015-06-25
US10639364B2 (en) 2020-05-05
US10010601B2 (en) 2018-07-03
MX2020010248A (es) 2020-10-16
JP2017502662A (ja) 2017-01-26
JP2020054380A (ja) 2020-04-09
EP3083947A1 (en) 2016-10-26
EA201600476A1 (ru) 2016-11-30
HUE061768T2 (hu) 2023-08-28
DK3591042T5 (da) 2024-09-02
AU2021201224A1 (en) 2021-03-11
EP3591042B1 (en) 2023-01-25
EP3083947B1 (en) 2019-04-03
US20160317642A1 (en) 2016-11-03
EA039060B1 (ru) 2021-11-29
US20190151432A1 (en) 2019-05-23
ES2940691T3 (es) 2023-05-10
AU2014369774A1 (en) 2016-04-21
WO2015092058A1 (en) 2015-06-25
JP7158523B2 (ja) 2022-10-21
AU2021201224B2 (en) 2023-06-15
KR20210080606A (ko) 2021-06-30
CN105829528A (zh) 2016-08-03
JP6886291B2 (ja) 2021-06-16

Similar Documents

Publication Publication Date Title
DK3083947T3 (da) Prrs-virusvariant, cdna-klon af europæisk prrs-virus, samt anvendelser deraf
DK3202086T3 (da) Tilstandsreplikation af virtuelle netværksfunktionsinstanser
DK2954051T3 (da) Modificeret kapsid til genoverførsel til behandling af nethinden
DK2970954T3 (da) Modifikation af polypeptider
DK2994159T3 (da) Forudsigelse af t-celleepitopers immunogenicitet
DK2968208T3 (da) Behandling af kataplexi
DK3083969T3 (da) System til produktion af virusvektor
DK3022163T3 (da) Glassammensætninger, glassammensætninger til fremstilling af glasfibre og deraf fremstillede glasfibre
DK2845905T3 (da) Fremstilling af oligosaccharider
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3087183T3 (da) Modulation af angiopoietin-3-lignende ekspression
DK3062606T3 (da) Forædling, fremstilling, forarbejdning og anvendelse af speciel cannabis
DK3083540T3 (da) Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner
DE112014001797A5 (de) Fliehkraftpendel
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK2961388T3 (da) Kombinationer af lægemidler
DK3079669T3 (da) Sammensætninger med forsinket frigivelse af linaclotid
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3380313T3 (da) Forbedringer vedrørende fremstillingen af vindmøllevinger
DK2965026T3 (da) Generering af slushice
DK2994488T3 (da) Anvendelse af c5ar-antagonister
EP2950886A4 (en) RSV F-PROTEIN EPITOPES
DK3511004T3 (da) Kombineret præparat til behandling af cancer
DK3065790T3 (da) Fremgangsmåder til fjernelse af alpha-galactose
DE112014003488A5 (de) Fliehkraftpendel